ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 97 filers reported holding ENDOCYTE INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $201,000 | +47.8% | 11,303 | -87.5% | 0.00% | – |
| Q2 2017 | $136,000 | -67.4% | 90,620 | -44.2% | 0.00% | -100.0% |
| Q1 2017 | $417,000 | +59.2% | 162,329 | +57.8% | 0.00% | – |
| Q4 2016 | $262,000 | +191.1% | 102,875 | +252.2% | 0.00% | – |
| Q3 2016 | $90,000 | +40.6% | 29,208 | +47.1% | 0.00% | – |
| Q2 2016 | $64,000 | +36.2% | 19,857 | +30.1% | 0.00% | – |
| Q1 2016 | $47,000 | -81.9% | 15,265 | +40.5% | 0.00% | -100.0% |
| Q1 2014 | $259,000 | +123.3% | 10,864 | -0.0% | 0.00% | – |
| Q4 2013 | $116,000 | -59.9% | 10,867 | -49.9% | 0.00% | -100.0% |
| Q3 2013 | $289,000 | +71.0% | 21,695 | +68.9% | 0.00% | – |
| Q2 2013 | $169,000 | – | 12,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
| Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
| PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
| Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
| Leisure Capital Management | 28,304 | $121,000 | 0.10% |
| Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
| EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
| SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
| Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
| Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |